The state of astragaloside IV research: A bibliometric and visualized analysis

Edaravone dexborneol protects cerebral ischemia reperfusion injury through activating Nrf2/HO‐1 signaling pathway in mice

(2022) Lili Xu et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Structural and Temporal Dynamics of Mesenchymal Stem Cells in Liver Diseases From 2001 to 2021: A Bibliometric Analysis

(2022) Bo Shao et al.   Frontiers in Immunology

Homoarginine treatment of rats improves cardiac function and remodeling in response to pressure overload

(2022) Vitali Koch et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Astragaloside IV alleviates silica‑induced pulmonary fibrosis via inactivation of the TGF‑β1/Smad2/3 signaling pathway

(2021) Nannan Li et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Global Trends and Performances of Magnetic Resonance Imaging Studies on Acupuncture: A Bibliometric Analysis

(2021) Jinhuan Zhang et al.   Frontiers in Neuroscience

Effects of physical activity on cell‐to‐cell communication during type 2 diabetes: A focus on miRNA signaling

(2021) Nabil Foudi et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Astragaloside alleviates alcoholic fatty liver disease by suppressing oxidative stress

(2021) Zhi‐Bin Jiang et al.   KAOHSIUNG JOURNAL OF MEDICAL SCIENCES

Astragaloside IV alleviates liver injury in type 2 diabetes due to promotion of AMPK/mTOR‑mediated autophagy

(2021) Yunfeng Zhu et al.   Molecular Medicine Reports

Astragaloside IV exerts anti-inflammatory role in endometriosis by downregulating TLR4/NF-κB pathway

(2021) Yongping Zhang et al.   TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH

Astragaloside IV Protects 6-Hydroxydopamine-Induced SH-SY5Y Cell Model of Parkinson’s Disease via Activating the JAK2/STAT3 Pathway

(2021) ZhengHu Xu et al.   Frontiers in Neuroscience

Astragaloside IV enhances the sensibility of lung adenocarcinoma cells to bevacizumab by inhibiting autophagy

(2021) Liang Li et al.   DRUG DEVELOPMENT RESEARCH

Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome‑mediated inflammation

(2021) Hui Feng et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Astragaloside IV prevents acute myocardial infarction by inhibiting the TLR4/MyD88/NF‐κB signaling pathway

(2021) Hui Shi et al.   JOURNAL OF FOOD BIOCHEMISTRY

Astragaloside IV alleviates heart failure by regulating SUMO‑specific protease 1

(2021) Juan Liu et al.   Experimental and Therapeutic Medicine

A Single, Acute Astragaloside IV Therapy Protects Cardiomyocyte Through Attenuating Superoxide Anion-Mediated Accumulation of Autophagosomes in Myocardial Ischemia-Reperfusion Injury

(2021) Kai-yu Huang et al.   Frontiers in Pharmacology

Astragaloside IV Alleviates the Experimental DSS-Induced Colitis by Remodeling Macrophage Polarization Through STAT Signaling

(2021) Lianlian Tian et al.   Frontiers in Immunology

A Bibliometric Analysis of Exosomes in Cardiovascular Diseases From 2001 to 2021

(2021) Dan Ma et al.   Frontiers in Cardiovascular Medicine

Astragaloside IV enhances GATA-4 mediated myocardial protection effect in Hypoxia/Reoxygenation injured H9c2 cells

(2020) Jing-Jing Yang et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Astragaloside IV as Potential Antioxidant Against Diabetic Ketoacidosis in Juvenile Mice Through Activating JNK/Nrf2 Signaling Pathway

(2020) Li-li Deng   ARCHIVES OF MEDICAL RESEARCH

A Scientometrics Analysis and Visualization of Depressive Disorder

(2020) Dong Xu et al.   Current Neuropharmacology

Astragaloside IV alleviates PM2.5-induced lung injury in rats by modulating TLR4/MyD88/NF-κB signalling pathway

(2020) Yongcan Wu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Angiogenic function of astragaloside IV in rats with myocardial infarction occurs via the PKD1‑HDAC5‑VEGF pathway

(2019) Lei Yang et al.   Experimental and Therapeutic Medicine

Astragaloside IV ameliorates high glucose‑induced HK‑2 cell apoptosis and oxidative stress by regulating the Nrf2/ARE signaling pathway

(2019) Jing Wang et al.   Experimental and Therapeutic Medicine

The effect of astragaloside IV on JAK2‐STAT6 signalling pathway in mouse model of ovalbumin‐induced asthma

(2019) Xinfu Yang et al.   JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION

Astragaloside IV exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN/PI3K/Akt signaling pathway

(2019) Songyi Cheng et al.   LIFE SCIENCES

Astragaloside IV Attenuates Myocardial Ischemia-Reperfusion Injury from Oxidative Stress by Regulating Succinate, Lysophospholipid Metabolism, and ROS Scavenging System

(2019) Miaomiao Jiang et al.   Oxidative Medicine and Cellular Longevity

Bibliometric and Visualized Analysis of Stem Cells Therapy for Spinal Cord Injury Based on Web of Science and CiteSpace in the Last 20 Years

(2019) Shengmin Guo et al.   World Neurosurgery

Astragaloside IV Protects Against Oxidative Stress in Calf Small Intestine Epithelial Cells via NFE2L2-Antioxidant Response Element Signaling

(2019) Yafang Wang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the Janus Kinase 2 and Signal Transducer and Activator of Transcription 3 Signaling Pathway

(2019) ZhengHu Xu et al.   PHARMACOLOGY

Quality evaluation for radix astragali based on fingerprint, indicative components selection and QAMS

(2018) Jun Huang et al.   BIOMEDICAL CHROMATOGRAPHY

Astragaloside suppresses apoptosis of the podocytes in rats with diabetic nephropathy via miR-378/TRAF5 signaling pathway

(2018) Xiao Lei et al.   LIFE SCIENCES

Astragaloside IV Attenuated 3,4-Benzopyrene-Induced Abdominal Aortic Aneurysm by Ameliorating Macrophage-Mediated Inflammation

(2018) Jiaoni Wang et al.   Frontiers in Pharmacology

Astragaloside IV enhances taxol chemosensitivity of breast cancer via caveolin-1-targeting oxidant damage

(2018) Yifeng Zheng et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Astragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4/NF-κB signaling pathway

(2018) Bin Leng et al.   LIFE SCIENCES

Astragaloside IV Attenuates Acetaminophen-Induced Liver Injuries in Mice by Activating the Nrf2 Signaling Pathway

(2018) Lei Li et al.   MOLECULES

Astragaloside IV Promotes Adult Neurogenesis in Hippocampal Dentate Gyrus of Mouse through CXCL1/CXCR2 Signaling

(2018) Fei Huang et al.   MOLECULES

Astragaloside IV/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats

(2018) Xiao Lei et al.   Drug Design Development and Therapy

Protective Effects of Astragaloside IV Combined with Budesonide in Bronchitis in Rats by Regulation of Nrf2/Keap1 Pathway

(2018) Zhijie Zhang et al.   MEDICAL SCIENCE MONITOR

Ganoderma: A Cancer Immunotherapy Review

(2018) Yu Cao et al.   Frontiers in Pharmacology

Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-кB in vivo and in vitro

(2017) Xiangjun Zhou et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Astragaloside IV attenuates cognitive impairments induced by transient cerebral ischemia and reperfusion in mice via anti-inflammatory mechanisms

(2017) Min Li et al.   NEUROSCIENCE LETTERS

Neuroprotective effects of astragaloside IV on Parkinson disease models of mice and primary astrocytes

(2017) Lei Xia et al.   Experimental and Therapeutic Medicine

Astragaloside IV Enhances Cisplatin Chemosensitivity in Non-Small Cell Lung Cancer Cells Through Inhibition of B7-H3

(2016) Cheng-Shi He et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Astragaloside IV alleviates E. coli -caused peritonitis via upregulation of neutrophil influx to the site of infection

(2016) Ping Huang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Astragaloside IV enhances diabetic wound healing involving upregulation of alternatively activated macrophages

(2016) Xiaochun Luo et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Astragaloside IV Enhances Cisplatin Chemosensitivity in Human Colorectal Cancer via Regulating NOTCH3

(2016) Tao Xie et al.   ONCOLOGY RESEARCH

Astragaloside IV ameliorates necrotizing enterocolitis by attenuating oxidative stress and suppressing inflammation via the vitamin D3-upregulated protein 1/NF-κB signaling pathway

(2016) Zhiyong Cai et al.   Experimental and Therapeutic Medicine

Antinociceptive activity of astragaloside IV in the animal model of chronic constriction injury

(2015) Guo-Bing Shi et al.   BEHAVIOURAL PHARMACOLOGY

Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB

(2015) LEI QIU et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Down-Regulation of PERK-ATF4-CHOP Pathway by Astragaloside IV is Associated with the Inhibition of Endoplasmic Reticulum Stress-Induced Podocyte Apoptosis in Diabetic Rats

(2014) Yifang Chen et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Astragaloside IV Stimulates Angiogenesis and Increases Nitric Oxide Accumulation via JAK2/STAT3 and ERK1/2 Pathway

(2013) Shi-Guang Wang et al.   MOLECULES

Accelerated sample preparation and formation of astragaloside IV in Astragali Radix

(2013) Marlene Monschein et al.   PHARMACEUTICAL BIOLOGY

Emerging trends in regenerative medicine: a scientometric analysis inCiteSpace

(2012) Chaomei Chen et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Trends in Ginseng Research in 2010

(2012) Si-Kwan Kim et al.   Journal of Ginseng Research